![Mark Neumann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Neumann
Corporate Officer/Principal chez
VERADERMICS, INCORPORATED
Profil
Mark Neumann is currently Chief Commercial & Strategy Officer at Veradermics, Inc. since 2025 and Chief Commercial Officer & Executive VP at Intra-Cellular Therapies, Inc. since 2018.
Formerly, Mr. Neumann was Vice President-Global Marketing at Amgen, Inc. from 2016 to 2018 and Vice President-Global Commercialization at Bristol Myers Squibb Co. from 2008 to 2014.
Education includes undergraduate studies at Lafayette College.
Postes actifs de Mark Neumann
| Sociétés | Poste | Début |
|---|---|---|
| VERADERMICS, INCORPORATED | Corporate Officer/Principal | 01/12/2025 |
Anciens postes connus de Mark Neumann
| Sociétés | Poste | Fin |
|---|---|---|
| INTRA-CELLULAR THERAPIES, INC. | Corporate Officer/Principal | 01/04/2025 |
| AMGEN INC. | Sales & Marketing | 01/09/2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/05/2014 |
Formation de Mark Neumann
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Lafayette College
 Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Intra-Cellular Therapies, Inc.
 Intra-Cellular Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes small molecule drugs to treat neuropsychiatric and neurological disorders | Health Technology |
Veradermics, Inc.
 Veradermics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company for treatment of dermatology and aesthetics problems | Health Technology |
Choisissez Zonebourse 
